Long-term anticoagulant effects of CYP2C9 and VKORC1 genotypes in phenprocoumon users

J Thromb Haemost. 2012 Dec;10(12):2610-2. doi: 10.1111/jth.12007.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / therapeutic use*
  • Aryl Hydrocarbon Hydroxylases / genetics*
  • Cytochrome P-450 CYP2C9
  • Genotype
  • Humans
  • Mixed Function Oxygenases / genetics*
  • Phenprocoumon / therapeutic use*
  • Vitamin K Epoxide Reductases

Substances

  • Anticoagulants
  • Mixed Function Oxygenases
  • CYP2C9 protein, human
  • Cytochrome P-450 CYP2C9
  • Aryl Hydrocarbon Hydroxylases
  • VKORC1 protein, human
  • Vitamin K Epoxide Reductases
  • Phenprocoumon